Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Canntab Therapeutics Limited    PILL   CA1377991023

CANNTAB THERAPEUTICS LIMITED

(PILL)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Canntab Therapeutics : IIROC Trade Resumption - PILL

09/21/2020 | 09:29am EST

VANCOUVER, BC, Sept. 21, 2020 /CNW/ - Trading resumes in:

Company: Canntab Therapeutics Limited

CSE Symbol: PILL

All Issues: Yes

Resumption (ET): 10:00 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC)

© Canada Newswire, source Canada Newswire English

All news about CANNTAB THERAPEUTICS LIMITED
2020Canntab Announces Closing of Convertible Debenture Private Placement
NE
2020Canntab Therapeutics Announces End of Supply and Distribution Agreements with..
NE
2020CANN GLOBAL : Canntab to Launch in Australia and Participate in Australia's Larg..
AQ
2020Canntab Announces Closing of Purchases of Cannabis Processing Equipment and L..
NE
2020CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL
AQ
2020CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..
AQ
2020CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL
AQ
2020CANNTAB THERAPEUTICS : announces planned purchases of cannabis processing equipm..
AQ
2020CANNTAB THERAPEUTICS : Appoints Larry Latowsky as CEO
AQ
2020CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL
AQ
More news
Financials
Sales 2020 0,13 M 0,11 M 0,11 M
Net income 2020 -2,61 M -2,06 M -2,06 M
Net cash 2020 1,36 M 1,08 M 1,08 M
P/E ratio 2020 -10,2x
Yield 2020 -
Capitalization 26,0 M 20,5 M 20,5 M
EV / Sales 2019 70,4x
EV / Sales 2020 231x
Nbr of Employees -
Free-Float 76,6%
Chart CANNTAB THERAPEUTICS LIMITED
Duration : Period :
Canntab Therapeutics Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Lawrence Latowsky Executive Chairman & Chief Executive Officer
Jeffrey W. Renwick President, Director & Head-Manufacturing
Richard Goldstein Chief Financial Officer & Director
Joshi Laxminarayan Chief Scientific Officer
Vitor Manuel Fonseca Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CANNTAB THERAPEUTICS LIMITED-8.75%20
CANOPY GROWTH CORPORATION36.43%12 487
CURALEAF HOLDINGS, INC.25.98%10 298
BEIJING TONGRENTANG CO., LTD5.86%5 324
TRULIEVE CANNABIS CORP.38.13%5 213
APHRIA INC.96.48%4 299